one8zero8 LLC Takes $394,000 Position in Encompass Health Co. (NYSE:EHC)

one8zero8 LLC purchased a new position in shares of Encompass Health Co. (NYSE:EHC) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 4,265 shares of the company’s stock, valued at approximately $394,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. KBC Group NV increased its position in shares of Encompass Health by 11.3% during the third quarter. KBC Group NV now owns 2,757 shares of the company’s stock worth $266,000 after purchasing an additional 279 shares in the last quarter. OneDigital Investment Advisors LLC acquired a new position in Encompass Health during the third quarter worth approximately $207,000. CIBC Asset Management Inc lifted its stake in Encompass Health by 3.5% in the third quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock valued at $286,000 after buying an additional 100 shares during the last quarter. Natixis Advisors LLC boosted its holdings in shares of Encompass Health by 7.8% in the third quarter. Natixis Advisors LLC now owns 101,296 shares of the company’s stock valued at $9,789,000 after acquiring an additional 7,294 shares during the period. Finally, Thrivent Financial for Lutherans grew its position in shares of Encompass Health by 26.0% during the third quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company’s stock worth $73,494,000 after acquiring an additional 156,938 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on EHC. Royal Bank of Canada reiterated an “outperform” rating and set a $110.00 price target on shares of Encompass Health in a research note on Tuesday, February 11th. William Blair reissued an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. KeyCorp boosted their price target on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Monday, February 10th. Barclays increased their price objective on Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, February 7th. Finally, StockNews.com raised Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, February 15th. Ten equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Encompass Health currently has a consensus rating of “Buy” and an average price target of $107.67.

Insider Activity at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 2.10% of the stock is currently owned by company insiders.

Encompass Health Trading Up 2.6 %

Shares of EHC stock opened at $96.11 on Monday. The business’s fifty day moving average price is $97.35 and its 200 day moving average price is $96.97. The firm has a market capitalization of $9.68 billion, a PE ratio of 21.55, a P/E/G ratio of 2.31 and a beta of 0.92. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. Encompass Health Co. has a 1-year low of $74.45 and a 1-year high of $104.55.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, sell-side analysts forecast that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s dividend payout ratio is currently 15.25%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.